NCT01540721View on ClinicalTrials.gov

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Subjects

Interventions

DRUG

Marketed paracetamol

marketed formulation

DRUG

Experimental paracetamol formulation

Experimental formulation

Trial Locations (1)

68501

MDS Pharma Services NEBRASKA, Lincoln

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY